Patents-Review.com
🔗 Permalink
Assignee profile:

ANDRX PHARMACEUTICALS, LLC

City:

Davie, Florida

Country:

United States

Published Applications:

14

Last publication date:

2013-10-01

Patent Grants:

13

Last grant date:

2013-10-01

Top Inventors for applications by ANDRX PHARMACEUTICALS, LLC

These are the the leading inventors for applications assigned to ANDRX PHARMACEUTICALS, LLC:

Recent patent applications by ANDRX PHARMACEUTICALS, LLC

ANDRX PHARMACEUTICALS, LLC based in Davie, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-10-01 ✅ Patent 8,545,880 granted on 2013-10-01
US10071257
-

Controlled release oral dosage form

 #2 | 2012-01-10 ✅ Patent 8,092,831 granted on 2012-01-10
US10291103
-

Antihistamine and decongestant system

 #3 | 2011-07-07 ✅ Patent 8,668,932 granted on 2014-03-11
US20110165234A1
Human necessities

Extended release venlafaxine formulation

 #4 | 2010-12-23
US20100323010A1
Human necessities

FORMULATION AND PROCESS FOR DRUG LOADED CORES

 #5 | 2010-11-04 ✅ Patent 8,747,898 granted on 2014-06-10
US20100278926A1
Human necessities

Controlled release oral dosage form

 #6 | 2009-05-14 ✅ Patent 8,628,797 granted on 2014-01-14
US20090124563A1
Human necessities

Oral extended-release composition

 #7 | 2009-03-26 ✅ Patent 7,931,915 granted on 2011-04-26
US20090081286A1
Human necessities

Extended release venlafaxine formulation

 #8 | 2008-02-21 ✅ Patent 7,790,200 granted on 2010-09-07
US20080044467A1
Human necessities

Formulation and process for drug loaded cores

 #9 | 2006-04-18 ✅ Patent 7,029,701 granted on 2006-04-18
US9950536
-

Composition for the treatment and prevention of ischemic events

 #10 | 2005-07-07 ✅ Patent 7,771,750 granted on 2010-08-10
US20050147678A1
Human necessities

Controlled release oral dosage form

 #11 | 2005-06-30 ✅ Patent 8,501,227 granted on 2013-08-06
US20050142195A1
Human necessities

Stable pharmaceutical compositions without a stabilizer

 #12 | 2005-05-19 ✅ Patent 7,470,435 granted on 2008-12-30
US20050106248A1
Human necessities

Extended release venlafaxine formulation

 #13 | 2005-03-24 ✅ Patent 7,476,403 granted on 2009-01-13
US20050064034A1
Human necessities

Oral extended-release composition

 #14 | 2005-02-24 ✅ Patent 8,529,946 granted on 2013-09-10
US20050042286A1
Human necessities

Rapidly disintegrating antihistamine formulation
AssigneeID:

214537 ⎘